Clinical Trial Update: Immune Response to SARS-CoV-2 Vaccination in Systemic Lupus

View source ↗

Summary

The clinical trial studying the immune response to SARS-CoV-2 vaccination in patients with Systemic lupus erythematosus has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Systemic Lupus | Status: TERMINATED